搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
The Pharma Letter
52 分钟
Change to the Roche enlarged corporate executive committee
Swiss pharm giant Roche today announced that Wafaa Mamilli will join the company as chief digital technology officer (CDTO), ...
The Pharma Letter
1 小时
Sarclisa wins MHRA nod for newly-diagnosed multiple myeloma
Days after the European Commission (EC) granted approval, the UK’s Medicines and Healthcare Regulatory Agency (MHRA) has ...
The Pharma Letter
1 小时
FDA approves Ozempic for patients with diabetes and CKD
In an important regulatory win for Denmark’s Novo Nordisk, the US Food and Drug Administration (FDA) yesterday approved ...
The Pharma Letter
2 小时
Teva reports year of growth with revenues up 6%
Israeli generics giant Teva Pharmaceutical Industries today reported results for the year and the quarter ended December 31, ...
The Pharma Letter
2 小时
BioAge rings the changes after azelaprag failure
A damaging trial failure in December wiped 70% off the share price of BioAge Labs, a US biopharma developing therapeutic ...
The Pharma Letter
4 小时
Amgen and Celltrion settle biosimilars patent dispute
US biotech major Amgen =announced that it has reached resolution of its patent infringement litigation related to South Korea ...
The Pharma Letter
4 小时
Lonza shares slip as sales stagnate
Switzerland-based Lonza Group was trading nearly 3% lower by lunchtime Wednesday after presenting its financial results for ...
The Pharma Letter
5 小时
Leap halts gastric cancer program, changes course
Leap Therapeutics is discontinuing the development of its anti-DKK1 antibody sirexatamab in gastric cancer after the drug ...
The Pharma Letter
6 小时
Alligator Bio announces publication of clinical data for ATOR-1017
Swedish immuno-oncology firm Alligator Bioscience today announced that clinical data for its 4-1BB agonist, ATOR-1017 ...
The Pharma Letter
6 小时
Servier delivers strong results for 2023/24 financial year
Independent French drugmaker Servier, which is governed by a foundation, has published its 2023/24 financial year results and ...
The Pharma Letter
5 小时
Another obesity contender launches, with $65 million
Biopharma start-up Helicore Biopharma has emerged from stealth with $65 million from a series A round co-led by Versant ...
The Pharma Letter
17 小时
Kailera snags Lilly’s Zepbound brand leader
Newly-launched obesity company Kailera Therapeutics has announced the appointment of Jamie Coleman as chief commercial ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈